PharmEasy raises fresh debt to clear Goldman Sachs loan after 90% valuation cut

▤ Summary

PharmEasy raised Rs 1,700 crore in debt led by 360 One to help repay its Goldman Sachs loan. The company is using the new borrowing to close out expensive legacy debt tied to earlier refinancing and its Thyrocare acquisition. This comes after a large capital raise in 2024 at a sharply reduced valuation, showing continued financial pressure. PharmEasy also reported flat FY25 revenue and a narrower loss, while leadership changes and co-founder exits continued over the past two years.

$ Funding

▦ Linked Companies